NewslettersPancreatic Cell News Recruitment Milestone Reached in Diamyd® Phase III Trial By Emily Salmini - April 16, 2024 0 Diamyd Medical’s precision medicine Phase III trial for Type 1 Diabetes, DIAGNODE-3, has enrolled 100 patients. To date, no serious adverse events have been reported, and no patients have discontinued the trial. [Diamyd Medical] Press Release